Animal Experiments at the German Federal Institute for Risk Assessment (BfR)

What is the BfR?

The Federal Institute for Risk Assessment (BfR) is Germanys leading scientific authority for the assessment of risks to consumer health. It provides independent, evidencebased advice on food, feed, consumer products, chemicals, and biological agents. While the institute strives to replace, reduce and refine animal use (the 3Rs), certain legal and scientific requirements still necessitate animal experiments.

Legal Framework

Animal experiments at the BfR are governed by a strict set of national and EU regulations:

• EU Directive 2010/63/EU the cornerstone of animal welfare in the EU, which obliges the implementation of the 3Rs.
• German Animal Protection Act (TierSchG) translates EU requirements into national law and adds additional safeguards.
• Animal Welfare Act (Tierschutzgesetz) requires that any experiment be justified, approved and performed by qualified personnel.
• Scientific Guidelines specific OECD test guidelines, GLP (Good Laboratory Practice) standards and BfR internal SOPs.

All projects must receive a licence from the competent authority (the regional authority for animal welfare) before any animal work can begin.

Why Animal Experiments Are Still Required

Although alternative methods have advanced considerably, some riskassessment questions cannot yet be answered without living organisms. Typical examples include:

• Toxicokinetic studies that track absorption, distribution, metabolism and excretion (ADME) of a substance in a wholebody context.
• Allergenicity testing for novel food proteins where immune response must be observed.
• Carcinogenicity assays (e.g., twoyear rodent bioassays) required for certain chemicals under EU law.
• Reproductive and developmental toxicity to assess potential effects on embryos and fetuses.

In each case, the BfR performs a thorough justification analysis, seeking the least invasive model that still provides reliable data.

The 3R Strategy at BfR

Implementing the 3Rs is a continuous, institutionwide effort. The main pillars are:

Replacement

Whenever possible, the institute uses:

• Invitro cell culture systems, including organonachip platforms.
• Computational models and readacross approaches.
• Data from existing studies (historical control data, literature).

Reduction

Strategies to lower animal numbers include:

• Poweranalysis to determine the smallest statistically valid group size.
• Sharing of control groups across compatible projects.
• Use of refined study designs such as stepwise testing.

Refinement

Improvements in animal welfare are applied at every stage:

• Environmental enrichment and social housing for rodents.
• Use of analgesics, anesthetics and humane endpoints.
• Training of staff in the latest handling and monitoring techniques.

Typical Animal Species Used

The BfR works with a limited range of species, selected for relevance to human health:

• Rodents (mice, rats) the most common model for toxicology, carcinogenicity and immunology.
• Rabbits used mainly for eye irritation tests and some developmental studies.
• Germfree or transgenic animals employed when specific metabolic pathways must be examined.

Quality Assurance and Transparency

All animal studies at the BfR are performed under Good Laboratory Practice (GLP). Key quality measures include:

• Independent audit of protocols and data.
• Documentation of each step in a secure electronic lab notebook.
• Public disclosure of study summaries in the BfRs annual report and on the official website.

Stakeholdersincluding NGOs, industry, and the general publiccan request detailed information about a specific study through a formal information request process.

Recent Developments (20232024)

During the last two years the institute has taken several notable steps:

• Adopted a new insilico platform for preliminary carcinogenicity prediction, reducing the need for confirmatory rodent studies by 20%.
• Implemented a nationwide collaboration on organoid technology, allowing the testing of food additives without animal use in 15% of cases.
• Published a refined 3Rguideline that integrates automated video monitoring to detect distress earlier, improving humane endpoints.

Public Engagement and Ethics

Recognising the ethical sensitivity of animal research, the BfR maintains an ongoing dialogue with the public:

• Annual public meetings where scientists present their work and answer questions.
• Educational outreach programmes in schools explaining the role of risk assessment and the 3Rs.
• Ethics review boards that include external experts and lay representatives.

These activities aim to build trust and ensure that societal values are reflected in research practice.

How You Can Learn More

For more detailed information, the following resources are available:

• BfR Animal Experiments Overview
• EU Directive 2010/63/EU official text
• OECD Test Guidelines OECD website
• 3Rs Centre global 3R initiatives

Conclusion

Animal experiments remain a necessary component of risk assessment at the German Federal Institute for Risk Assessment, but they are performed under a rigorous framework that prioritises animal welfare, scientific validity and transparency. Continuous investment in alternative methods, strict adherence to the 3Rs, and open communication with the public ensure that the institute balances the need for reliable safety data with ethical responsibility.